Literature DB >> 15572296

Percutaneous endoscopic gastrostomy for long-term feeding of patients with oropharyngeal tumors.

Thomas Anwander1, Stefaan Bergé, Thorsten Appel, Jens-Jörg von Lindern, Markus Martini, Jens Mommsen, Jochen Kipnowski, Bernd Niederhagen.   

Abstract

Secondary malnutrition in patients with oropharyngeal tumors can be the cause of substantial morbidity. The present, prospective study examined 30 patients receiving treatment for an oropharyngeal tumor. Percutaneous endoscopic gastrostomy (PEG) was performed 1 wk prior to the start of therapy in 15 patients, and 15 patients were temporarily fed by nasogastric tube after surgery. Anthropometric and laboratory parameters were measured in both patient groups at five defined times. Based on these parameters, the nutritional status of the PEG patients was found to be substantially better. The present study was able to show that the prophylactic placement of a PEG tube greatly improves the nutritional status of the patients before and after surgery and minimizes the catabolism of the body's fat depots.

Entities:  

Mesh:

Year:  2004        PMID: 15572296     DOI: 10.1207/s15327914nc5001_6

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  3 in total

1.  Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin.

Authors:  Wuyang Yang; Todd R McNutt; Sara A Dudley; Rachit Kumar; Heather M Starmer; Christine G Gourin; Joseph A Moore; Kimberly Evans; Mysha Allen; Nishant Agrawal; Jeremy D Richmon; Christine H Chung; Harry Quon
Journal:  Dysphagia       Date:  2016-01-11       Impact factor: 3.438

2.  Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)?

Authors:  Mohammad F Madhoun; Matt M Blankenship; Derek M Blankenship; Greg A Krempl; William M Tierney
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

3.  Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis.

Authors:  Claire Barber; Roy Powell; Annie Ellis; Julie Hewett
Journal:  Support Care Cancer       Date:  2006-11-28       Impact factor: 3.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.